ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (ANEB) is scheduled to report Q3 earnings on May 29, 2026. Analysts estimate EPS of $-0.14 and quarterly revenue of N/A.
In the most recent quarter (Q2), ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc reported EPS of $-0.05, beating estimates of $-0.13 by 0.62%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc has averaged an EPS surprise of 0.35% and a revenue surprise of 0.00%.
Analyze the earnings history of ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc using advanced sorting and filters.
The chart below shows ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc's reported EPS compared to analyst estimates over recent quarters.
The chart below shows ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc's reported revenue compared to analyst estimates over recent quarters.
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (ANEB) is scheduled to report earnings on May 29, 2026. The last reported earnings were for reported on February 12, 2026 for Q2.
The Actual EPS was $-0.05, which beat the estimate of $-0.13.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2026-02-12 | $-0.05 | $-0.13 | 61.5 % |
| Q1 | 2025-11-13 | $-0.05 | $-0.12 | 58.3 % |
| Q4 | 2025-09-29 | $-0.05 | $-0.05 | 0.00 % |
| Q3 | 2025-05-13 | $-0.04 | $-0.05 | 20.0 % |